Looks like it, but in terms of medicines at least there is huge variation between what is available, and who has access for it, and how it is paid for in different EU countries, even if they all take the EMA regulatory approval. In normal times regulatory approval is just the first step in setting prices and access levels on a country by country basis, even within the EU. It’s not a single unified bloc in this area. The EU itself has nothing to do with the negotiation, purchase and distribution of medicines, even vaccines, and man it shows now.Ok mate.
I mentioned The Guardian as I hoped it would give me more gravitas with you lefties.
So does this mean that the Germans are going to behave differently to the rest of the EU?
The negotiations which happen after regulatory approval is a big part of my job, though from a bit of a distance nowadays.
